Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial
作者： Robert C. G. Martin , Charles R. Scoggins , Dana Tomalty , Marshall Schreeder , Tiffany Metzger
DOI: 10.1007/S11605-012-1892-8
关键词:
摘要: Purpose The primary objective of this study is to evaluate the safety, tolerance, and pharmacokinetic profile liver-directed therapy with drug-eluting beads irinotecan (DEBIRI) in combination systemic modified FOLFOX treatment unresectable liver metastases chemotherapy-naive patients colorectal cancer.
springer.com
sci-hub.se 参考文章(26)
Scheele J, Stangl R, Gall Fp, Altendorf-Hofmann A, Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery. ,vol. 110, pp. 13- 29 ,(1991)
WILLIAM R. WELCH, STANLEY J. ROBBOY, DUANE E. TOWNSEND, ANN B. BARNES, ROBERT E. SCULLY, ARTHUR L. HERBST, Comparison of Histologic and Colposcopic Findings in Des-exposed Females Annals of Surgery. ,vol. 189, pp. 332- 333 ,(1979) , 10.1097/00000658-197904000-00027
Maja J. A. de Jonge, Jaap Verweij, Peter de Bruijn, Eric Brouwer, Ron H. J. Mathijssen, Robbert J. van Alphen, Maureen M. de Boer-Dennert, Laurent Vernillet, Christian Jacques, Alex Sparreboom, Pharmacokinetic, Metabolic, and Pharmacodynamic Profiles in a Dose-Escalating Study of Irinotecan and Cisplatin Journal of Clinical Oncology. ,vol. 18, pp. 195- 195 ,(2000) , 10.1200/JCO.2000.18.1.195
Jean-Nicolas Vauthey, Michael A. Choti, W. Scott Helton, AHPBA/SSO/SSAT Consensus Conference on Hepatic Colorectal Metastases: Rationale and Overview of the Conference Annals of Surgical Oncology. ,vol. 13, pp. 1259- 1260 ,(2006) , 10.1245/S10434-006-9017-9
Robert CG Martin, Ken Robbins, Dana Tomalty, Ryan O'Hara, Petar Bosnjakovic, Radek Padr, Miloslav Rocek, Frantisek Slauf, Alexander Scupchenko, Cliff Tatum, Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report World Journal of Surgical Oncology. ,vol. 7, pp. 80- 80 ,(2009) , 10.1186/1477-7819-7-80
Russell E. Brown, Matthew R. Bower, Tiffany L. Metzger, Charles R. Scoggins, Kelly M. McMasters, Michael J. Hahl, Cliff Tatum, Robert C.G. Martin, Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe? Hpb. ,vol. 13, pp. 91- 95 ,(2011) , 10.1111/J.1477-2574.2010.00246.X
S L Cheeseman, S P Joel, J D Chester, G Wilson, J T Dent, F J Richards, M T Seymour, A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. British Journal of Cancer. ,vol. 87, pp. 393- 399 ,(2002) , 10.1038/SJ.BJC.6600467
E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) European Journal of Cancer. ,vol. 45, pp. 228- 247 ,(2009) , 10.1016/J.EJCA.2008.10.026
Thomas Aparicio, Michel Flesch, Charles Varette, Aimery de Gramont, Oncology Multidisciplinary Research Group (GERCOR), Mohamed Hebbar, Christophe Tournigand, Gérard Lledo, May Mabro, Thierry André, Christophe Louvet, Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study). Cancer Investigation. ,vol. 24, pp. 154- 159 ,(2006) , 10.1080/07357900500524397
A Jenal, R Siegel, E Ward, T Murray, J Xu, C Smigal, Cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 52, pp. 23- 47 ,(2002) , 10.3322/CANJCLIN.52.1.23